Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.062 | 0.7 |